Growth Metrics

Hyperfine (HYPR) Cash from Financing Activities (2021 - 2026)

Hyperfine posted quarterly Cash from Financing Activities of $14.5 million for Q1 2026, up 159.51% year-on-year from $5.6 million in Q1 2025, and down 24.87% on a QoQ basis from $19.3 million in Q4 2025.

Hyperfine (HYPR) has 6 years of Cash from Financing Activities data on file, last reported at $14.5 million in Q1 2026.

  • For the quarter ending Q1 2026, Cash from Financing Activities rose 159.51% year-over-year to $14.5 million; the trailing twelve-month figure through Mar 2026 stood at $36.4 million (up 456.16% YoY), and the FY2025 full-year result was $27.5 million, up 2598.92% from the prior year.
  • Cash from Financing Activities for Q1 2026 stood at $14.5 million, down from $19.3 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $19.3 million in Q4 2025 and bottomed at $5000.0 in Q4 2022.
  • The 5-year median for Cash from Financing Activities is $58500.0 (2023), against an average of $3.1 million.
  • The widest annual swing landed in 2022, when Cash from Financing Activities plunged 100.0%; it then jumped 35607.41% in 2025.
  • A 5-year view of Cash from Financing Activities shows it stood at $5000.0 in 2022, then soared by 460.0% to $28000.0 in 2023, then soared by 92.86% to $54000.0 in 2024, then surged by 35607.41% to $19.3 million in 2025, then declined by 24.87% to $14.5 million in 2026.
  • The last three Cash from Financing Activities figures came in at $14.5 million (Q1 2026), $19.3 million (Q4 2025), and $2.2 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 17.31 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -1.51 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -2.09 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -260.00 Mn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -451.20 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -26.93 Mn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -25.00 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 21.00 Mn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -97.90 Mn
10 Hyperfine 149.47 Mn 108.20 Mn 1.98 Mn 14.49 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 14.49 Mn
Mar 31, 2026 14.49 Mn
Dec 31, 2025 19.28 Mn
Dec 31, 2025 19.28 Mn
Sep 30, 2025 2.16 Mn
Sep 30, 2025 2.16 Mn
Jun 30, 2025 474,000.00
Jun 30, 2025 474,000.00
Mar 31, 2025 5.58 Mn
Mar 31, 2025 5.58 Mn
Dec 31, 2024 54,000.00
Dec 31, 2024 54,000.00
Sep 30, 2024 851,000.00
Sep 30, 2024 851,000.00
Jun 30, 2024 59,000.00
Jun 30, 2024 59,000.00
Mar 31, 2024 55,000.00
Mar 31, 2024 55,000.00
Dec 31, 2023 28,000.00
Dec 31, 2023 28,000.00
Sep 30, 2023 39,000.00
Sep 30, 2023 39,000.00
Jun 30, 2023 58,000.00
Jun 30, 2023 58,000.00
Mar 31, 2023 49,000.00
Mar 31, 2023 49,000.00
Dec 31, 2022 5,000.00
Dec 31, 2022 5,000.00
Dec 31, 2021 141.33 Mn
Dec 31, 2021 141.33 Mn
Sep 30, 2021 1.26 Mn
Sep 30, 2021 1.26 Mn
Jun 30, 2021 2.97 Mn
Jun 30, 2021 2.97 Mn
Mar 31, 2021 31.21 Mn
Mar 31, 2021 31.21 Mn